-
Emergent BioSolutions receives FDA OK for OTC Narcan Nasal Spray
Narcan Naloxone HCl Nasal Spray 4 mg is the first and only spray to receive over-the-counter status in the United States. -
FDA advisory committee votes in support of Pfizer’s Paxlovid
The committee voted 16 to 1 that available data support the safety and effectiveness of Paxlovid for treating mild to moderate COVID-19 in adult patients at high risk for progression to severe illness.